Daniel L. Zimbroff

691 total citations
5 papers, 436 citations indexed

About

Daniel L. Zimbroff is a scholar working on Experimental and Cognitive Psychology, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Daniel L. Zimbroff has authored 5 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Experimental and Cognitive Psychology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Clinical Psychology. Recurrent topics in Daniel L. Zimbroff's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Stress Responses and Cortisol (1 paper). Daniel L. Zimbroff is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Neurotransmitter Receptor Influence on Behavior (2 papers) and Stress Responses and Cortisol (1 paper). Daniel L. Zimbroff collaborates with scholars based in United States and Germany. Daniel L. Zimbroff's co-authors include Karl Rickels, Mark H. Pollack, Douglas E. Feltner, Gwen L. Zornberg, Robert J. Bielski, Atul C. Pande, R. Bruce Lydiard, Howard Feldman, Ruth Ross and Anantha Shekhar and has published in prestigious journals such as The Journal of Clinical Psychiatry, Depression and Anxiety and Journal of Clinical Psychopharmacology.

In The Last Decade

Daniel L. Zimbroff

5 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel L. Zimbroff United States 4 150 126 114 103 84 5 436
Vasilios G. Masdrakis Greece 14 137 0.9× 126 1.0× 248 2.2× 142 1.4× 66 0.8× 45 535
Bijan Etemad United States 7 104 0.7× 123 1.0× 92 0.8× 109 1.1× 31 0.4× 10 375
Christian Barnas Austria 13 78 0.5× 70 0.6× 230 2.0× 101 1.0× 40 0.5× 25 515
Gabriella Rapini Italy 14 100 0.7× 231 1.8× 306 2.7× 106 1.0× 43 0.5× 19 627
Michel Schittecatte Netherlands 10 136 0.9× 84 0.7× 79 0.7× 113 1.1× 67 0.8× 19 372
Massimo C. Mauri Italy 11 88 0.6× 201 1.6× 105 0.9× 55 0.5× 21 0.3× 18 520
Margarita Shekotikhina Canada 13 131 0.9× 77 0.6× 178 1.6× 230 2.2× 110 1.3× 18 603
J Weissenburger France 7 83 0.6× 44 0.3× 70 0.6× 117 1.1× 33 0.4× 15 362
Stephen T.H. Sokolov Canada 11 56 0.4× 53 0.4× 149 1.3× 172 1.7× 38 0.5× 13 370
Joseph Pultz United States 8 36 0.2× 115 0.9× 296 2.6× 85 0.8× 82 1.0× 11 526

Countries citing papers authored by Daniel L. Zimbroff

Since Specialization
Citations

This map shows the geographic impact of Daniel L. Zimbroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel L. Zimbroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel L. Zimbroff more than expected).

Fields of papers citing papers by Daniel L. Zimbroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel L. Zimbroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel L. Zimbroff. The network helps show where Daniel L. Zimbroff may publish in the future.

Co-authorship network of co-authors of Daniel L. Zimbroff

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel L. Zimbroff. A scholar is included among the top collaborators of Daniel L. Zimbroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel L. Zimbroff. Daniel L. Zimbroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Allen, Michael H., David Feifel, Michael D. Lesem, et al.. (2011). Efficacy and Safety of Loxapine for Inhalation in the Treatment of Agitation in Patients With Schizophrenia. The Journal of Clinical Psychiatry. 72(10). 1313–1321. 68 indexed citations
2.
Coric, Vladimir, Howard Feldman, Dan A. Oren, et al.. (2010). Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depression and Anxiety. 27(5). 417–425. 136 indexed citations
3.
Rickels, Karl, Sanjay J. Mathew, Michael Banov, et al.. (2008). Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 28(2). 235–239. 18 indexed citations
4.
Rickels, Karl, Mark H. Pollack, Douglas E. Feltner, et al.. (2005). Pregabalin for Treatment of Generalized Anxiety Disorder. Archives of General Psychiatry. 62(9). 1022–1022. 213 indexed citations
5.
Zimbroff, Daniel L., et al.. (2001). Patient and rater education of expectations in clinical trails (PREECT): An approach to reducing placebo response rates in acute depression trials. European Neuropsychopharmacology. 11. S193–S193. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026